Active Ingredient(s):Atazanavir + Cobicistat FDA Approved: * January 29, 2015 Pharm Company: *BRISTOL MYERS SQUIBB Category:HIV / AIDS
Atazanavir, sold under the brand name Reyataz among others, is an antiretroviral medication used to treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure (postexposure prophylaxis (PEP)). It is taken by mouth once a day.
Common side effects include headache, nausea, yellowish skin, abdominal pain, trouble sle...
* May have multiple approval dates, manufacturers, or labelers.